Citation: M. Maboudianesfahani et Dr. Brocks, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF (+ -)-ETHOPROPAZINE AND ITS ENANTIOMERS IN RAT PLASMA/, Journal of chromatography B. Biomedical sciences and applications, 715(2), 1998, pp. 417-423
Authors:
BROCKS DR
UPWARD J
DAVY M
HOWLAND K
COMPTON C
MCHUGH C
DENNIS MJ
Citation: Dr. Brocks et al., EVENING DOSING IS ASSOCIATED WITH HIGHER PLASMA-CONCENTRATIONS OF PRANLUKAST, A LEUKOTRIENE RECEPTOR ANTAGONIST, IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 44(3), 1997, pp. 289-291
Authors:
BROCKS DR
UPWARD J
HUST R
KOESTER FE
COLLIE H
QIAN Y
DENNIS MJ
Citation: Dr. Brocks et al., THE PHARMACOKINETICS OF PRANLUKAST IN HEALTHY-YOUNG AND ELDERLY SUBJECTS, International journal of clinical pharmacology and therapeutics, 34(9), 1996, pp. 375-379
Authors:
BROCKS DR
FREED MI
MARTIN DE
SELLERS TS
MEHDI N
CITERONE DR
BOPPANA V
LEVITT B
DAVIES BE
NEMUNAITIS J
JORKASKY DK
Citation: Dr. Brocks et al., INTERSPECIES PHARMACOKINETICS OF A NOVEL HEMATOREGULATORY PEPTIDE (SK-AND-F-107647) IN RATS, DOGS, AND ONCOLOGIC PATIENTS, Pharmaceutical research, 13(5), 1996, pp. 794-797
Authors:
BROCKS DR
MEIKLE AW
BOIKE SC
MAZER NA
ZARIFFA N
AUDET PR
JORKASKY DK
Citation: Dr. Brocks et al., PHARMACOKINETICS OF TESTOSTERONE IN HYPOGONADAL MEN AFTER TRANSDERMALDELIVERY - INFLUENCE OF DOSE, Journal of clinical pharmacology, 36(8), 1996, pp. 732-739
Authors:
BROCKS DR
UPWARD JW
GEORGIOU P
STELMAN G
DOYLE E
ALLEN E
WYLD P
DENNIS MJ
Citation: Dr. Brocks et al., THE SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF PRANLUKAST IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 303-308
Citation: Dr. Brocks et al., A LIQUID-CHROMATOGRAPHIC ASSAY FOR THE STEREOSPECIFIC QUANTITATIVE-ANALYSIS OF HALOFANTRINE IN HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 13(7), 1995, pp. 911-918
Citation: Kj. Skeith et Dr. Brocks, PHARMACOKINETIC OPTIMIZATION OF THE TREATMENT OF OSTEOARTHRITIS, Clinical pharmacokinetics, 26(3), 1994, pp. 233-242
Citation: Dr. Brocks et al., INFLUENCE OF THE ROUTE OF ADMINISTRATION ON THE PHARMACOKINETICS OF PIRPROFEN ENANTIOMERS IN THE RAT, Chirality, 5(2), 1993, pp. 61-64